Main Menu

Myeloma Group

Dr Richard Houlston's Group is investigating new personalised treatments for the blood cancers myeloma.

Team leader

Professor Richard Houlston

Professor Richard Houlston

Professor of Molecular and Population Genetics

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer.

ORCID 0000-0002-5268-0242

Team members

Dr Andrea Gunnell
Dr Andrea Gunnell
Higher Scientific Officer ORCID 0000-0001-5162-5391

Dr Andrea Gunnell is a cell biologist working on the identification of new predisposition alleles for myeloma through GWAS analysis and molecular genetic functional studies to elucidate biological basis for genetic susceptibility.

 Kim Sharp
Kim Sharp
Scientific Officer

I joined the team in 2018 and I execute the processing, biobanking and biomarker profiling of clinical samples from national myeloma clinical trials. I use flow cytometry and molecular biology techniques established in our laboratory to detect genetic aberrations in patient samples.

Dr Shalini Singh
Dr Shalini Singh
Postdoctoral Training Fellow ORCID 0000-0001-9300-3822

I am currently investigating the molecular mechanism of drug resistance in multiple myeloma using molecular and cell biology techniques.

 George Waldron
George Waldron
Scientific Officer

I joined the team in January 2020 and work on the processing of myeloma clinical trial samples. I utilise molecular biology techniques and flow cytometry to assess genetic and immunological changes in patient samples.

Katerina Panopoulou
MD Fellow